Lista de obras -

Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A.

artículo científico publicado en 2013

Biomarkers for screening, diagnosis, and monitoring of ovarian cancer

artículo científico publicado en 2012

Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element

scientific article published on 11 May 2018

Clinical utility of CA-125 in the management of uterine carcinosarcoma

scientific article published on 01 November 2018

Disease-free interval after primary treatment predicts prognosis of recurrent endometrial carcinoma.

artículo científico publicado en 2010

Endometrial carcinoma: better prognosis for asymptomatic recurrences than for symptomatic cases found by routine follow-up.

artículo científico publicado en 2010

Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma

artículo científico publicado en 2017

LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake.

artículo científico publicado en 2017

Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.

artículo científico publicado en 2012

Prediction, based on resection margins, of long-term outcome of cervical intraepithelial neoplasia 3 treated by Shimodaira-Taniguchi conization

artículo científico publicado en 2011

Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma

artículo científico publicado en 2018

Recurrent endometrial carcinoma: prognosis for patients with recurrence within 6 to 12 months is worse relative to those relapsing at 12 months or later

artículo científico publicado en 2011

Salvage chemotherapy for ovarian carcinoma recurring during or after consolidation chemotherapy with paclitaxel

artículo científico publicado en 2011

Salvage chemotherapy with taxane and platinum for women with recurrent uterine carcinosarcoma.

artículo científico publicado en 2017

Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin

artículo científico publicado en 2010

Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma

artículo científico publicado en 2018

Significance of venous thromboembolism in women with uterine carcinosarcoma

artículo científico publicado en 2017

Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion.

artículo científico

Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery.

artículo científico publicado en 2017

Tumor characteristics and outcome of uterine carcinosarcoma in women aged ≥80 years

artículo científico publicado en 2019

Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma

artículo científico publicado en 2016

Lista de obras de

Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A.

Biomarkers for screening, diagnosis, and monitoring of ovarian cancer

Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element

Clinical utility of CA-125 in the management of uterine carcinosarcoma

Disease-free interval after primary treatment predicts prognosis of recurrent endometrial carcinoma.

Endometrial carcinoma: better prognosis for asymptomatic recurrences than for symptomatic cases found by routine follow-up.

Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma

LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake.

Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.

Prediction, based on resection margins, of long-term outcome of cervical intraepithelial neoplasia 3 treated by Shimodaira-Taniguchi conization

Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma

Recurrent endometrial carcinoma: prognosis for patients with recurrence within 6 to 12 months is worse relative to those relapsing at 12 months or later

Salvage chemotherapy for ovarian carcinoma recurring during or after consolidation chemotherapy with paclitaxel

Salvage chemotherapy with taxane and platinum for women with recurrent uterine carcinosarcoma.

Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin

Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma

Significance of venous thromboembolism in women with uterine carcinosarcoma

Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion.

Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery.

Tumor characteristics and outcome of uterine carcinosarcoma in women aged ≥80 years

Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma